Brian Roberts

Important data-quality note. The stub record supplied for "Brian Roberts" appears to conflate at least two or three different people who share this very common name, so I have researched the identifiers rather than assumed a single coherent person:

1. Evaluation Associates Brian Roberts — The primary email domain (`evaluationassociates.com`) and the "Institutional Investors" firm type point to Brian Roberts, listed on LinkedIn as an Institutional Liaison at Evaluation Associates. Evaluation Associates is a long-established institutional investment-consulting firm founded in 1969 in Norwalk, CT, advising corporate retirement plans, endowments, foundations, and other institutional portfolios. At its peak it reported roughly $200 billion in assets under advisement across ~115 clients. In 2011, Mercer Investment Consulting acquired most of the firm (its public-sector consulting business went to Callan Associates); the "Evaluation Associates" name has since continued under the Milliman/Mercer corporate lineage. Beyond his job title, no substantive verifiable biographical detail (education, dated career history, deal activity) is publicly available for this specific individual.

2. Insulet / Omnipod Brian Roberts — The second email (`[hidden]`) and the +1 (781) 457-5000 Massachusetts number map to Insulet Corporation (Nasdaq: PODD), maker of the Omnipod insulin pump. A Brian Roberts served as Insulet's Chief Financial Officer, departing in 2020. Public bios describe ~30 years in finance, a start at Ernst & Young, a CPA, and a B.S. in Accounting/Finance from Boston College; he later became CEO of Tarveda Therapeutics (which he joined as CFO in 2018) and, in November 2023, CFO of Sensata Technologies. This is an operator/CFO, not a seed-stage investor.

3. Possible third identity — A prominent, unrelated Brian Roberts is a General Partner at Andreessen Horowitz (former CFO of Lyft and Splunk, ex-Evercore/Microsoft/Walmart). Nothing in the stub's contact data ties to a16z, so he is noted only to rule him out, not claimed as the subject.

The remaining phone numbers in the stub — (503) 813-5000 (Oregon) and (44) 19 3283-6270 (UK) — could not be tied to any of the above with confidence and are not reproduced as verified contacts.

• No published, attributable investment thesis could be found for the Brian Roberts at Evaluation Associates.
• Evaluation Associates' work is institutional investment consulting (manager selection, asset allocation, and fiduciary advice for pensions, endowments, and foundations) rather than direct seed/venture investing — so the stub's "Seed Round" tag is not supported by any source and is treated as unverified.
• Any thesis quote would be fabrication; none is asserted here.